mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |